Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion type Assertion NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_head.
- NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion wasGeneratedBy ECO_0000203 NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_provenance.
- NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion wasDerivedFrom befree-20140225 NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_provenance.
- NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion SIO_000772 19095153 NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_provenance.
- NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion evidence source_evidence_literature NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_provenance.
- NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_assertion description "[The strongest genetic risk for the development of melanoma results from heritable alterations in cyclin-dependent kinase inhibitor 2A (CDKN2A) gene, which encodes two separate but related proteins, p16/INK4a and p14/ARF.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP416559.RANKLnkEQ8z-EZfjM-2srlk10wMBcfgVMuBMsT2IBdnLg130_provenance.